Susquehanna International Group
VTYX

Susquehanna International Group’s Ventyx Biosciences VTYX Stock Holding History

Susquehanna International Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,118,275
Closed -$10.1M – 14204
2025
Q4 		$10.1M Buy
1,118,275
+438,297
+64% +$3.28M ﹤0.01% 3025
2025
Q3 		$2.11M Buy
679,978
+192,998
+40% +$511K ﹤0.01% 5662
2025
Q2 		$1.04M Buy
486,980
+214,223
+79% +$346K ﹤0.01% 7318
2025
Q1 		$314K Buy
272,757
+120,121
+79% +$206K ﹤0.01% 9979
2024
Q4 		$334K Buy
152,636
+86,899
+132% +$197K ﹤0.01% 9587
2024
Q3 		$143K Buy
65,737
+34,302
+109% +$78.9K ﹤0.01% 10786
2024
Q2 		$72.6K Sell
31,435
-86,143
-73% -$358K ﹤0.01% 11225
2024
Q1 		$647K Sell
117,578
-205,762
-64% -$941K ﹤0.01% 7892
2023
Q4 		$799K Buy
+323,340
New +$3.07M ﹤0.01% 7550
2023
Q3 		– Sell
-13,219
Closed -$457K – 13096
2023
Q2 		$434K Buy
13,219
+2,788
+27% +$96.1K ﹤0.01% 8644
2023
Q1 		$349K Buy
+10,431
New +$406K ﹤0.01% 9384
2022
Q4 		– Sell
-19,114
Closed -$667K – 13800
2022
Q3 		$667K Buy
+19,114
New +$423K ﹤0.01% 7699

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's VTYX Position: Q1 2026 in Review

Susquehanna International Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 1,118,275 shares — an estimated $10.1M sold.

Susquehanna International Group first reported a position in VTYX in Q3 2022 and held it in 12 quarters. The position peaked at $10.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Susquehanna International Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,118,275 Ventyx Biosciences shares in Q1 2026, an estimated $10.1M.
  • Susquehanna International Group first reported a position in Ventyx Biosciences in Q3 2022 and held it in 12 quarters.
  • Susquehanna International Group's Ventyx Biosciences position peaked at $10.1M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.